The iPhone 6 Is Selling Like Crazy
AP
The iPhone 6 and 6 Plus accounted for 90% of iPhone sales during that time, according to the survey, meaning practically everyone buying an iPhone got the latest and greatest model. That's up from 84% of buyers choosing the iPhone 5S or 5C during the first 30 days last year.
UBS found that Chinese customers are very interested in the iPhone 6 and 19% of current Samsung phone owners plan to switch to iPhone. The iPhone 6 Plus appears to be slightly more popular in China too, with a little over half of respondents telling UBS they plan to buy one over the iPhone 6.
Here's the latest on iPhone 6 demand in China from a UBS research note released Friday:
Our recent UBS Evidence Lab study complements the backward-looking CIRP work in finding impressive iPhone 6 buying intentions. Over 40% of respondents were likely to buy an iPhone 6 in the next year with China surprisingly strong. There is clear share gain-19% of Samsung users look to switch to Apple for their next purchase. It also found a tilt toward the 6 Plus at over half of indicated purchases. CIRP data show the smaller iPhone 6 is selling more than the 6 Plus, which we expect to continue. But due to supply shortages, we don't know the underlying 6 Plus demand. The Evidence Lab study suggests the 6 Plus could exceed expectations, especially in Asia.
- I got a $40K raise using this 30-second strategy. It made me realize loud work, not hard work, always wins.
- Qatar Airways' new CEO explains why it's sticking with the Airbus A380 as other airlines retire the costly superjumbo
- Prince Harry and Meghan found out about Kate Middleton's cancer diagnosis on TV like everyone else, report says
- Kia India looks to expand sales, service network to 700 touchpoints by year-end
- Shapoorji Pallonji’s Afcons Infra files DRHP for ₹7,000 crore IPO
- Water crisis affects businesses across Bengaluru; Is there room for cautious optimism?
- BenQ Zowie EC2-CW review – Premium wireless mouse for gamers
- Banks' GNPAs set to improve further to 2.1 pc by FY25: Care Ratings